Literature DB >> 28131126

The Role of the Osteocyte in Bone and Nonbone Disease.

Lynda F Bonewald1.   

Abstract

When normal physiologic functions go awry, disorders and disease occur. This is universal; even for the osteocyte, a cell embedded within the mineralized matrix of bone. It was once thought that this cell was simply a placeholder in bone. Within the last decade, the number of studies of osteocytes has increased dramatically, leading to the discovery of novel functions of these cells. With the discovery of novel physiologic functions came the discoveries of how these cells can also be responsible for not only bone diseases and disorders, but also those of the kidney, heart, and potentially muscle.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone disease; FGF23; Osteocyte; Sclerostin; Therapeutics

Mesh:

Year:  2016        PMID: 28131126      PMCID: PMC5300041          DOI: 10.1016/j.ecl.2016.09.003

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  132 in total

1.  Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation.

Authors:  Hai Qing; Laleh Ardeshirpour; Paola Divieti Pajevic; Vladimir Dusevich; Katharina Jähn; Shigeaki Kato; John Wysolmerski; Lynda F Bonewald
Journal:  J Bone Miner Res       Date:  2012-05       Impact factor: 6.741

Review 2.  Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability.

Authors:  Teresita Bellido; Lilian I Plotkin
Journal:  Bone       Date:  2010-08-18       Impact factor: 4.398

3.  Estrogen receptor α in osteocytes regulates trabecular bone formation in female mice.

Authors:  Shino Kondoh; Kazuki Inoue; Katsuhide Igarashi; Hiroe Sugizaki; Yuko Shirode-Fukuda; Erina Inoue; Taiyong Yu; Jun K Takeuchi; Jun Kanno; Lynda F Bonewald; Yuuki Imai
Journal:  Bone       Date:  2013-12-10       Impact factor: 4.398

4.  Identification of signal peptide domain SOST mutations in autosomal dominant craniodiaphyseal dysplasia.

Authors:  Su Jin Kim; Tadeusz Bieganski; Young Bae Sohn; Kazimierz Kozlowski; Mikhail Semënov; Nobuhiko Okamoto; Chi Hwa Kim; Ah-Ra Ko; Geung Hwan Ahn; Yoon-La Choi; Sung Won Park; Chang-Seok Ki; Ok-Hwa Kim; Gen Nishimura; Sheila Unger; Andrea Superti-Furga; Dong-Kyu Jin
Journal:  Hum Genet       Date:  2011-01-09       Impact factor: 4.132

5.  Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip.

Authors:  R S Weinstein; R W Nicholas; S C Manolagas
Journal:  J Clin Endocrinol Metab       Date:  2000-08       Impact factor: 5.958

6.  Inducible cyclo-oxygenase (COX-2) mediates the induction of bone formation by mechanical loading in vivo.

Authors:  M R Forwood
Journal:  J Bone Miner Res       Date:  1996-11       Impact factor: 6.741

7.  FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy.

Authors:  Chad D Touchberry; Troy M Green; Vladimir Tchikrizov; Jaimee E Mannix; Tiffany F Mao; Brandon W Carney; Magdy Girgis; Robert J Vincent; Lori A Wetmore; Buddhadeb Dawn; Lynda F Bonewald; Jason R Stubbs; Michael J Wacker
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-02-26       Impact factor: 4.310

8.  Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis.

Authors:  Xiaodong Li; Michael S Ominsky; Kelly S Warmington; Sean Morony; Jianhua Gong; Jin Cao; Yongming Gao; Victoria Shalhoub; Barbara Tipton; Raj Haldankar; Qing Chen; Aaron Winters; Tom Boone; Zhaopo Geng; Qing-Tian Niu; Hua Zhu Ke; Paul J Kostenuik; W Scott Simonet; David L Lacey; Chris Paszty
Journal:  J Bone Miner Res       Date:  2009-04       Impact factor: 6.741

9.  Relationship between circulating FGF23 and total body atherosclerosis in the community.

Authors:  Majd A I Mirza; Tomas Hansen; Lars Johansson; Håkan Ahlström; Anders Larsson; Lars Lind; Tobias E Larsson
Journal:  Nephrol Dial Transplant       Date:  2009-05-09       Impact factor: 5.992

10.  Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength.

Authors:  Xiaodong Li; Michael S Ominsky; Qing-Tian Niu; Ning Sun; Betsy Daugherty; Diane D'Agostin; Carole Kurahara; Yongming Gao; Jin Cao; Jianhua Gong; Frank Asuncion; Mauricio Barrero; Kelly Warmington; Denise Dwyer; Marina Stolina; Sean Morony; Ildiko Sarosi; Paul J Kostenuik; David L Lacey; W Scott Simonet; Hua Zhu Ke; Chris Paszty
Journal:  J Bone Miner Res       Date:  2008-06       Impact factor: 6.741

View more
  30 in total

1.  IDG-SW3 Osteocyte Differentiation and Bone Extracellular Matrix Deposition Are Enhanced in a 3D Matrix Metalloproteinase-Sensitive Hydrogel.

Authors:  Aaron H Aziz; Rachel L Wilmoth; Virginia L Ferguson; Stephanie J Bryant
Journal:  ACS Appl Bio Mater       Date:  2020-02-19

Review 2.  Osteoblast migration in vertebrate bone.

Authors:  Antonia Thiel; Marie K Reumann; Adele Boskey; Johannes Wischmann; Rüdiger von Eisenhart-Rothe; Philipp Mayer-Kuckuk
Journal:  Biol Rev Camb Philos Soc       Date:  2017-06-19

Review 3.  In Vivo Osteocyte Mechanotransduction: Recent Developments and Future Directions.

Authors:  Paige V Hinton; Susan M Rackard; Oran D Kennedy
Journal:  Curr Osteoporos Rep       Date:  2018-12       Impact factor: 5.096

4.  Cathepsin K-deficient osteocytes prevent lactation-induced bone loss and parathyroid hormone suppression.

Authors:  Sutada Lotinun; Yoshihito Ishihara; Kenichi Nagano; Riku Kiviranta; Vincent T Carpentier; Lynn Neff; Virginia Parkman; Noriko Ide; Dorothy Hu; Pamela Dann; Daniel Brooks; Mary L Bouxsein; John Wysolmerski; Francesca Gori; Roland Baron
Journal:  J Clin Invest       Date:  2019-05-21       Impact factor: 14.808

Review 5.  The roles of Orai and Stim in bone health and disease.

Authors:  Lisa J Robinson; Harry C Blair; John B Barnett; Jonathan Soboloff
Journal:  Cell Calcium       Date:  2019-06-05       Impact factor: 6.817

6.  Osteocyte Death and Bone Overgrowth in Mice Lacking Fibroblast Growth Factor Receptors 1 and 2 in Mature Osteoblasts and Osteocytes.

Authors:  Jennifer McKenzie; Craig Smith; Kannan Karuppaiah; Joshua Langberg; Matthew J Silva; David M Ornitz
Journal:  J Bone Miner Res       Date:  2019-06-17       Impact factor: 6.741

7.  Case report: Electron microscopic evaluation of bone from a patient treated with cinacalcet hydrochloride, maxacalcitol, and alfacalcidol for hyperparathyroid bone disease with secondary hyperparathyroidism.

Authors:  A Yajima; K Tsuchiya; L F Bonewald; M Inaba; Y Tominaga; T Tanizawa; A Ito; K Nitta
Journal:  Osteoporos Int       Date:  2018-02-28       Impact factor: 4.507

Review 8.  Skeletal dynamics of Down syndrome: A developing perspective.

Authors:  Jonathan M LaCombe; Randall J Roper
Journal:  Bone       Date:  2019-12-27       Impact factor: 4.398

9.  [Observation of dendrite osteocytes of mice at different developmental stages using Ploton silver staining and phalloidin staining].

Authors:  Shuhao Feng; Liangxiao Bao; Gengtao Qiu; Zheting Liao; Zhonghao Deng; Nachun Chen; Yuhao Chu; Ziheng Luo; Yu Jin; Xiaoyu Li; Yingzi Yang; Liang Zhao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-11-30

10.  Radium-223-Induced Bystander Effects Cause DNA Damage and Apoptosis in Disseminated Tumor Cells in Bone Marrow.

Authors:  Brian S Canter; Calvin N Leung; J Christopher Fritton; Tom Bäck; Didier Rajon; Edouard I Azzam; Roger W Howell
Journal:  Mol Cancer Res       Date:  2021-05-26       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.